27 Apr 2015
NeurOp Announces Strategic Collaboration with Johnson & Johnson Innovation to St ...
2 Oct 2014
NeurOp Receives Milestone Payment as Bristol-Myers Squibb Nominates NMDA Recepto ...
Our most advanced compounds for major depression, neuropathic pain and ischemia demonstrate efficacy in animal models with no
apparent toxicity at therapeutic doses. The chart below shows the progress towards our goal of placing a drug candidate in human